Merus N.V.
MRUSDelisted Dec 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651311
Merus N.V. was delisted on Dec 30, 2025; its insiders filed their last Form 4 on Dec 30, 2025; 268 institutions reported holding it in 13F filings for Q3 2025, worth $6.70B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Merus N.V. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 201
- +18 vs. Q1 2025
- Shares held
- 74.8M
- +3.98M (+5.6%) vs. Q1 2025
- Total value
- $3.93B
- +$952.5M (+31.9%) vs. Q1 2025
- New holders
- 47
- 76 more added
- Sold out
- 29
- 65 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 10 | $5.73M |
| Q3 2025 | 268 | $6.70B |
| Q2 2025 | 201 | $3.93B |
| Q1 2025 | 185 | $2.98B |
| Q4 2024 | 192 | $2.96B |
| Q3 2024 | 189 | $3.45B |
| Q2 2024 | 179 | $3.94B |
| Q1 2024 | 156 | $2.31B |
| Q4 2023 | 131 | $1.41B |
| Q3 2023 | 113 | $1.12B |
| Q2 2023 | 114 | $1.09B |
| Q1 2023 | 104 | $672.0M |
| Q4 2022 | 91 | $563.8M |
| Q3 2022 | 100 | $687.4M |
| Q2 2022 | 93 | $793.4M |
| Q1 2022 | 95 | $878.1M |
| Q4 2021 | 103 | $1.05B |
| Q3 2021 | 64 | $487.8M |
| Q2 2021 | 68 | $564.3M |
| Q1 2021 | 59 | $558.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Merus N.V.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 7,490,377 | $394.0M | 0.02% | +523,463+7.5% | Added |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −373,100−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −237,156−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −156,915−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −120,038−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −107,101−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −106,532−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −47,956−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −45,942−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −29,612−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −24,870−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −18,156−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −16,616−100.0% | Sold out |
| Fieldview Capital Management, LLC | 0 | $0 | 0.00% | −12,797−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −7,381−100.0% | Sold out |
| Kazazian Asset Management, LLC | 0 | $0 | 0.00% | −6,368−100.0% | Sold out |
| Net Worth Advisory Group | 0 | $0 | 0.00% | −5,054−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −2,698−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,794−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,253−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −223−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |